Avoca signs astaxanthin agreement with Synthetic Genomics
date:Jun 25, 2014
chnology, SGI has developed algae with a higher level of astaxanthin, and as a result, we can provide 7.5% astaxanthin oleoresin with the concentration increasing over time as the algae strain and production technology is improved.

We are very pleased to enter into this agreement with Avoca, said Jon Getzinger, sr. vice president, SGI. Our ability to develop advantaged nutraceutical and human and animal feed ingredients coupled with Avoca's ability to process and market those products, makes th
3/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/08 13:07